Kimberly Blackwell - Net Worth and Insider Trading
Kimberly Blackwell Net Worth
The estimated net worth of Kimberly Blackwell is at least $1 Million dollars as of 2024-11-10. Kimberly Blackwell is the CEO of Zentalis Pharmaceuticals Inc and owns about 254,800 shares of Zentalis Pharmaceuticals Inc (ZNTL) stock worth over $1 Million. Details can be seen in Kimberly Blackwell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kimberly Blackwell has not made any transactions after 2023-11-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kimberly Blackwell
Kimberly Blackwell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kimberly Blackwell owns 3 companies in total, including Zentalis Pharmaceuticals Inc (ZNTL) , Monte Rosa Therapeutics Inc (GLUE) , and Century Therapeutics Inc (IPSC) .
Click here to see the complete history of Kimberly Blackwell’s form 4 insider trades.
Insider Ownership Summary of Kimberly Blackwell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals Inc | 2023-11-13 | director |
| GLUE | Monte Rosa Therapeutics Inc | 2021-06-23 | director |
| IPSC | Century Therapeutics Inc | 2022-06-09 | director |
Kimberly Blackwell Latest Holdings Summary
Kimberly Blackwell currently owns a total of 1 stock. Kimberly Blackwell owns 254,800 shares of Zentalis Pharmaceuticals Inc (ZNTL) as of November 13, 2023, with a value of $1 Million.
Latest Holdings of Kimberly Blackwell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals Inc | 2023-11-13 | 254,800 | 3.96 | 1,009,008 |
Holding Weightings of Kimberly Blackwell
Kimberly Blackwell Form 4 Trading Tracker
According to the SEC Form 4 filings, Kimberly Blackwell has made a total of 5 transactions in Zentalis Pharmaceuticals Inc (ZNTL) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Zentalis Pharmaceuticals Inc is the acquisition of 5,000 shares on November 13, 2023, which cost Kimberly Blackwell around $51,450.
Insider Trading History of Kimberly Blackwell
- 1
Kimberly Blackwell Trading Performance
GuruFocus tracks the stock performance after each of Kimberly Blackwell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kimberly Blackwell is 5.56%. GuruFocus also compares Kimberly Blackwell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kimberly Blackwell within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kimberly Blackwell's insider trading performs compared to the benchmark.
Performance of Kimberly Blackwell
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 47.86 | | | | | |
| Relative Return to S&P 500(%) | 41.16 | | | | | |
Kimberly Blackwell Ownership Network
Ownership Network List of Kimberly Blackwell
Ownership Network Relation of Kimberly Blackwell
Kimberly Blackwell Owned Company Details
What does Zentalis Pharmaceuticals Inc do?
Who are the key executives at Zentalis Pharmaceuticals Inc?
Kimberly Blackwell is the director of Zentalis Pharmaceuticals Inc. Other key executives at Zentalis Pharmaceuticals Inc include Chief Financial Officer Melissa B, Epperly , General Counsel Andrea Paul , and Chief Medical Officer Carrie Brownstein .
Zentalis Pharmaceuticals Inc (ZNTL) Insider Trades Summary
Over the past 18 months, Kimberly Blackwell made 1 insider transaction in Zentalis Pharmaceuticals Inc (ZNTL) with a net purchase of 5,000. Other recent insider transactions involving Zentalis Pharmaceuticals Inc (ZNTL) include a net sale of 50,090 shares made by Cam Gallagher , a net sale of 16,724 shares made by Melissa B, Epperly , and a net sale of 86,068 shares made by Kevin D. Bunker .
In summary, during the past 3 months, insiders sold 1,603 shares of Zentalis Pharmaceuticals Inc (ZNTL) in total and bought 0 shares, with a net sale of 1,603 shares. During the past 18 months, 178,364 shares of Zentalis Pharmaceuticals Inc (ZNTL) were sold and 22,000 shares were bought by its insiders, resulting in a net sale of 156,364 shares.
Zentalis Pharmaceuticals Inc (ZNTL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zentalis Pharmaceuticals Inc Insider Transactions
Kimberly Blackwell Mailing Address
Above is the net worth, insider trading, and ownership report for Kimberly Blackwell. You might contact Kimberly Blackwell via mailing address: C/o Zentalis Pharmaceuticals, Llc, 530 Seventh Avenue, Suite 2201, New York Ny 10018.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
